Skip to content

Clinical trials

Recruiting Phase 2 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Status: Recruiting Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20183
20191
20203
20217
20227
202318
202419
202530
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting104

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China9
Memorial Sloan Kettering Cancer Center5
Janssen Research & Development, LLC4
M.D. Anderson Cancer Center4
Mayo Clinic4
Massachusetts General Hospital3
National Cancer Institute (NCI)3
SCRI Development Innovations, LLC3
City of Hope Medical Center2
Dickran Kazandjian, MD2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma104
Recurrence13
Lymphoma, Non-Hodgkin7
Hodgkin Disease6
Leukemia, Plasma Cell5
Myelodysplastic Syndromes5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Bites and Stings3
Breast Neoplasms3
Cytokine Release Syndrome3

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.